60 related articles for article (PubMed ID: 26413777)
1. VEGF-A mRNA measurement in meningiomas using a new simplified approach: branched DNA and chemiluminescence.
Dyrbye H; Nassehi D; Sørensen LP; Juhler M; Laursen H; Broholm H
Clin Neuropathol; 2016; 35(1):13-21. PubMed ID: 26413777
[TBL] [Abstract][Full Text] [Related]
2. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema.
Nassehi D; Dyrbye H; Andresen M; Thomsen C; Juhler M; Laursen H; Broholm H
APMIS; 2011 Dec; 119(12):831-43. PubMed ID: 22085359
[TBL] [Abstract][Full Text] [Related]
5. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas.
Kalkanis SN; Carroll RS; Zhang J; Zamani AA; Black PM
J Neurosurg; 1996 Dec; 85(6):1095-101. PubMed ID: 8929501
[TBL] [Abstract][Full Text] [Related]
6. Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway.
Nassehi D; Sørensen LP; Dyrbye H; Thomsen C; Juhler M; Laursen H; Broholm H
APMIS; 2013 Nov; 121(11):1025-36. PubMed ID: 23398358
[TBL] [Abstract][Full Text] [Related]
7. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
[TBL] [Abstract][Full Text] [Related]
8. Optimizing gDNA extraction from fresh frozen meningioma tissue for downstream genetic analysis.
Proctor DT; Yoo EH; Vujadinovic Z; Lama S; van Marle G; Sutherland GR
Clin Biochem; 2017 Mar; 50(4-5):194-205. PubMed ID: 27871894
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
10. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
Berkman RA; Merrill MJ; Reinhold WC; Monacci WT; Saxena A; Clark WC; Robertson JT; Ali IU; Oldfield EH
J Clin Invest; 1993 Jan; 91(1):153-9. PubMed ID: 8380810
[TBL] [Abstract][Full Text] [Related]
11. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ROS1 oncogene for tyrosine receptor kinase in adult human meningiomas.
Zhao JF; Sharma S
Cancer Genet Cytogenet; 1995 Sep; 83(2):148-54. PubMed ID: 7553586
[TBL] [Abstract][Full Text] [Related]
13. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
14. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
15. Structure and expression of the c-sis gene and its relationship to sporadic meningiomas.
Smidt M; Dumanski JP; Collins VP; Ratner L
Cancer Res; 1991 Aug; 51(16):4295-8. PubMed ID: 1868450
[TBL] [Abstract][Full Text] [Related]
16. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
[TBL] [Abstract][Full Text] [Related]
17. [Expression of integrin-alpha 3 mRNA in meningiomas and its biological significance].
Chen J; Xu XP
Ai Zheng; 2002 May; 21(5):526-9. PubMed ID: 12452046
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy induces an increase in the expression of glyceraldehyde-3-phosphate dehydrogenase in uterine artery endothelial cells.
Cale JM; Millican DS; Itoh H; Magness RR; Bird IM
J Soc Gynecol Investig; 1997; 4(6):284-92. PubMed ID: 9408883
[TBL] [Abstract][Full Text] [Related]
20. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
Barresi V; Tuccari G
Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
